quinazolines has been researched along with zm 252868 in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrow, D; Dutkowski, CM; Harper, ME; Jones, HE; Nicholson, RI; Wakeling, AE | 1 |
Arteaga, CL; Guyer, CA; Ramsey, TT; Shawver, LK | 1 |
Bartlett, JM; Gordge, P; Langdon, SP; Leake, RE; Macleod, KG; Miller, EP; Miller, WR; Rabiasz, G; Rae, AL; Simpson, BJ; Smyth, J | 1 |
Ben-Bassat, H; Chaouat, M; Chen, H; Gazit, A; Harzstark, Z; Klein, BY; Levitzki, A; Levitzki, R; McCollough, J; McMahon, J; Narog, B; Powell, TJ; Shawver, L; Shenoy, N; Tang, C | 1 |
Arteaga, CL; Busse, D; Doughty, RS; Flanagan, WM; Price, JO; Ramsey, TT; Russell, WE; Shawver, LK | 1 |
Barrow, D; Dutkowski, CM; Goddard, L; Harper, ME; Jones, HE; Nicholson, RI; Smith, C | 1 |
Assender, J; Barrow, D; Dewhurst, OL; Dutkowski, CM; Glynne-Jones, E; Goddard, L; Harper, ME; Nicholson, RI; Wakeling, AE | 1 |
Grunt, TW | 1 |
Banasik, M; Dytnerska, K; Lewkowicz, N; Lewkowicz, P; Tchórzewski, H | 1 |
Almenara, JA; Campbell, DJ; Dewitt, JL; Oyesanya, RA; Sirica, AE; Zhang, Z | 1 |
10 other study(ies) available for quinazolines and zm 252868
Article | Year |
---|---|
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.
Topics: Cell Division; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Phosphorylation; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tumor Cells, Cultured | 1997 |
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
Topics: Adenosine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Binding Sites; Carrier Proteins; Dimerization; Enzyme Inhibitors; ErbB Receptors; Glycoproteins; Humans; Ligands; Neuregulin-1; Nitriles; Phosphorylation; Protein Binding; Protein Conformation; Quinazolines; Receptor, ErbB-2; Signal Transduction; Tumor Cells, Cultured; Tyrphostins | 1997 |
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Topics: Cell Division; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Ovarian Neoplasms; Phosphorylation; Proto-Oncogene Proteins; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1999 |
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors.
Topics: Animals; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermis; ErbB Receptors; Humans; Keratinocytes; Mice; Psoriasis; Quinazolines; Skin Absorption; Tumor Cells, Cultured; Tyrphostins | 1999 |
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.
Topics: Animals; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; ErbB Receptors; Female; G1 Phase; Humans; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinazolines; Retinoblastoma Protein; Tumor Suppressor Proteins; Tyrphostins; Up-Regulation | 2000 |
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.
Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Division; Drug Interactions; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Nitriles; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tosyl Compounds; Tumor Cells, Cultured | 2001 |
Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
Topics: Adenocarcinoma; Apoptosis; Blotting, Northern; Blotting, Western; Cell Count; Cell Cycle; Cell Division; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Quinazolines; RNA, Messenger; Signal Transduction; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2002 |
Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells.
Topics: Adenocarcinoma; Apoptosis; Benzothiazoles; Cell Division; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Quinazolines; Receptor, ErbB-2; Tretinoin; Tumor Cells, Cultured; Tyrphostins | 2003 |
Epidermal growth factor enhances TNF-alpha-induced priming of human neutrophils.
Topics: CD11b Antigen; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Humans; Inflammation; Interleukin-8; Neutrophils; Phagocytosis; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species; Respiratory Burst; Tumor Necrosis Factor-alpha; Tyrphostins | 2005 |
Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; ErbB Receptors; Humans; Lapatinib; Protein Kinase Inhibitors; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction; Tyrphostins | 2010 |